Statin use does not affect survival outcomes for ALS patients, so there may be no need to stop taking them after a diagnosis, per a study.

End-of-life care can be complicated for patients and physicians. Learn how the AMA can help your residents meet this challenge head-on.

The first study participant was enrolled in July 2024, and since that time, the consortium has recruited over 300 participants.

Welcome back to the “Life in 2050” series! So far, we’ve looked at how ongoing developments in science, technology, and geopolitics will be reflected in terms of warfare and the economy.

Individuals nearing the end of life often sleep a lot more. This can make it challenging to know if their loved one is in pain. However, even at rest, there are signs of discomfort that you can watch ...

People diagnosed with amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder also known as Lou Gehrig's disease, have a life expectancy of two to five years. They become trapped ...

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing: The ALS share price is ...

WATCH: Thanks to an ALS drug recently approved by Health Canada, a Regina woman says she regained a quality of life. Angela Stewart has the story.

32,951 people played the daily Crossword recently. Can you solve it faster than others?32,951 people played the daily Crossword recently. Can you solve it faster than others?

Tiziana Life Sciences is seeking regulatory clearance in the U.S. to launch a Phase 2 clinical trial evaluating foralumab nasal spray, its lead therapeutic candidate, as a treatment for amyotrophic ...

A nurse who helps care for people at the end of their lives has spoken out about some of the more unnerving things people do before they die in an effort to help loved ones be 'prepared'. Julie ...

Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the company to mull the asset’s future. The therapy, dubbed DNL343 ...